Anthem Inc. Announces Changes to Leadership Team
October 05 2021 - 5:00PM
Business Wire
Anthem, Inc. (NYSE: ANTM) announced today organizational changes
to the senior leadership team reflecting the company’s continued
positioning for future growth and preparing to meet the evolving
needs of the industry, its consumers and the communities they
serve.
“The breadth and depth of our leadership ensures that we stand
ready to deliver on our promises to those we are privileged to
serve and our commitment to drive health beyond healthcare,” said
Gail Boudreaux, President and CEO. “Collectively, these individuals
are industry leaders who are dedicated to driving growth, change
and innovation as we work to become a lifetime, trusted health
partner.”
The following changes are effective Tuesday, October 5:
- Pete Haytaian will lead Anthem’s diversified business
group and IngenioRx as Executive Vice President and President,
Diversified Business and IngenioRx. Most recently, Haytaian
served as President of Commercial and Specialty Business, where for
the past three years he has delivered industry-leading growth,
while responding to economic and market pressures, as well as
uncertainty amid the pandemic. Having also led Anthem’s Government
Business Division through transformative growth, Haytaian brings to
this role a deep knowledge of the healthcare industry and Anthem’s
government and commercial businesses and the potential of the
company’s diversified business and pharmacy benefits business.
- Morgan Kendrick will lead Anthem’s commercial business,
as Executive Vice President and President, Commercial and
Specialty Business Division, joining Anthem’s Senior Leadership
Team. Kendrick joined Anthem in 1995 and has driven innovation and
market-leading growth across key lines of commercial business
including in his roles as President of Anthem National Accounts and
President of Commercial Business in Georgia. Kendrick has served as
President of the Commercial West Markets since 2020, leading the
performance, growth, and strategic direction for Anthem’s
commercial business in California, Colorado, Indiana, Kentucky,
Missouri, Nevada, Ohio, and Wisconsin, as well as Specialty sales
across the company’s 14 local commercial markets.
- Rajeev Ronanki has been named President, Digital
Platforms, joining Anthem’s Senior Leadership Team. As the
company accelerates its strategy to become a digital platform for
health, Ronanki will be responsible for growing and commercializing
Anthem’s digital capabilities for consumers, care providers, and
the health ecosystem as the company works to reinvent care
delivery, operations, and interactions. Since joining Anthem in
2018, Ronanki has led Anthem’s digital transformation by developing
our digital-first approach across our Digital, Artificial
Intelligence (AI), Exponential Technology, Service Experience, and
Innovation portfolios.
About Anthem, Inc.
Anthem is a leading health benefits company dedicated to
improving lives and communities, and making healthcare simpler.
Through its affiliated companies, Anthem serves more than 117
million people, including more than 44 million within its family of
health plans. We aim to be the most innovative, valuable and
inclusive partner. For more information, please visit
www.antheminc.com or follow @AnthemInc on Twitter.
Forward-Looking Statements
This document contains certain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements reflect our views about future
events and financial performance and are generally not historical
facts. Words such as “expect,” “feel,” “believe,” “will,” “may,”
“should,” “anticipate,” “intend,” “estimate,” “project,”
“forecast,” “plan” and similar expressions are intended to identify
forward-looking statements. These statements include, but are not
limited to: financial projections and estimates and their
underlying assumptions; statements regarding plans, objectives and
expectations with respect to future operations, products and
services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of
which are difficult to predict and generally beyond our control,
that could cause actual results to differ materially from those
expressed in, or implied or projected by, the forward-looking
statements. You are cautioned not to place undue reliance on these
forward- looking statements that speak only as of the date hereof.
You are also urged to carefully review and consider the various
risks and other disclosures discussed in our reports filed with the
U.S. Securities and Exchange Commission from time to time, which
attempt to advise interested parties of the factors that affect our
business. Except to the extent otherwise required by federal
securities laws, we do not undertake any obligation to republish
revised forward-looking statements to reflect events or
circumstances after the date hereof. These risks and uncertainties
include, but are not limited to: the impact of large scale medical
emergencies, such as public health epidemics and pandemics,
including COVID-19, and catastrophes; trends in healthcare costs
and utilization rates; our ability to secure sufficient premium
rates, including regulatory approval for and implementation of such
rates; the impact of federal and state regulation, including
ongoing changes in the Patient Protection and Affordable Care Act
and the Health Care and Education Reconciliation Act of 2010, as
amended; changes in economic and market conditions, as well as
regulations that may negatively affect our liquidity and investment
portfolios; our ability to contract with providers on
cost-effective and competitive terms; competitive pressures and our
ability to adapt to changes in the industry and develop and
implement strategic growth opportunities; reduced enrollment;
unauthorized disclosure of member or employee sensitive or
confidential information, including the impact and outcome of any
investigations, inquiries, claims and litigation related thereto;
risks and uncertainties regarding Medicare and Medicaid programs,
including those related to non-compliance with the complex
regulations imposed thereon; our ability to maintain and achieve
improvement in Centers for Medicare and Medicaid Services Star
ratings and other quality scores and funding risks with respect to
revenue received from participation therein; a negative change in
our healthcare product mix; costs and other liabilities associated
with litigation, government investigations, audits or reviews;
risks and uncertainties related to our pharmacy benefit management
(“PBM”), business including non-compliance by any party with the
PBM services agreement between us and CaremarkPCS Health, L.L.C.;
medical malpractice or professional liability claims or other risks
related to healthcare and PBM services provided by our
subsidiaries; general risks associated with mergers, acquisitions,
joint ventures and strategic alliances; changes in U.S. tax laws;
possible impairment of the value of our intangible assets if future
results do not adequately support goodwill and other intangible
assets; possible restrictions in the payment of dividends from our
subsidiaries and increases in required minimum levels of capital;
our ability to repurchase shares of our common stock and pay
dividends on our common stock due to the adequacy of our cash flow
and earnings and other considerations; the potential negative
effect from our substantial amount of outstanding indebtedness; a
downgrade in our financial strength ratings; the effects of any
negative publicity related to the health benefits industry in
general or us in particular; failure to effectively maintain and
modernize our information systems; events that may negatively
affect our licenses with the Blue Cross and Blue Shield
Association; the impact of international laws and regulations;
intense competition to attract and retain employees; and various
laws and provisions in our governing documents that may prevent or
discourage takeovers and business combinations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211005006188/en/
Investor Relations: Stephen Tanal
Stephen.tanal@anthem.com
Media Relations: Michelle Vanstory
Michelle.vanstory@anthem.com
Anthem (NYSE:ANTM)
Historical Stock Chart
From May 2024 to Jun 2024
Anthem (NYSE:ANTM)
Historical Stock Chart
From Jun 2023 to Jun 2024